NCT01908478View on ClinicalTrials.gov

Veliparib in Combination With Gemcitabine and Intensity Modulated Radiation Therapy in Patients With Pancreatic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

October 2, 2013

Primary Completion Date

July 14, 2017

Study Completion Date

July 6, 2020

Conditions
Pancreatic Cancer
Interventions
DRUG

Veliparib

DRUG

Gemcitabine

RADIATION

Intensity modulated radiation therapy

Trial Locations (1)

90048

Cedars-Sinai Medical Center, Los Angeles

Sponsors

Collaborators (1)

AbbVie
All Listed Sponsors
collaborator

AbbVie

INDUSTRY

lead

Cedars-Sinai Medical Center

OTHER